A new indication for gamma hydroxybutyrate (Xyrem) in narcolepsy.
D002492:Central Nervous System Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009290:Narcolepsy / Q000188:drug therapy*; D012978:Sodium Oxybate / Q000009:adverse effects / Q000627:therapeutic use*
D002492:Central Nervous System Depressants; D012978:Sodium Oxybate